Chennai Meenakshi Multispeciality Hospital Limited

BSE:523489 Stock Report

Market Cap: ₹324.3m

Chennai Meenakshi Multispeciality Hospital Past Earnings Performance

Past criteria checks 0/6

Chennai Meenakshi Multispeciality Hospital's earnings have been declining at an average annual rate of -9.4%, while the Healthcare industry saw earnings growing at 23.2% annually. Revenues have been growing at an average rate of 9.9% per year.

Key information

-9.4%

Earnings growth rate

-9.5%

EPS growth rate

Healthcare Industry Growth29.4%
Revenue growth rate9.9%
Return on equityn/a
Net Margin-4.2%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Chennai Meenakshi Multispeciality Hospital makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

BSE:523489 Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24364-15100
30 Jun 24379-800
31 Mar 24382-4100
31 Dec 23288390
30 Sep 23287790
30 Jun 23287900
31 Mar 23387990
31 Dec 22280280
30 Sep 22274080
30 Jun 22263-100
31 Mar 223144080
31 Dec 213044490
30 Sep 212914290
30 Jun 212784000
31 Mar 21195-1290
31 Dec 20201-1580
30 Sep 20212-1180
30 Jun 20228-580
31 Mar 20258580
31 Dec 19248560
30 Sep 19241160
30 Jun 19230-100
31 Mar 19224060
31 Dec 18225550
30 Sep 18222650
30 Jun 182291100
31 Mar 182351550
31 Dec 172311650
30 Sep 172181050
30 Jun 17203050
31 Mar 17190-1150
31 Dec 16184-1250
30 Sep 16191-650
30 Jun 16200100
31 Mar 16205750
31 Dec 15198-4270
30 Sep 15194-7240
30 Jun 15187-12250
31 Mar 15189-1030
31 Dec 141930310
30 Sep 141871290
30 Jun 141845640
31 Mar 141794240
31 Dec 131777250

Quality Earnings: 523489 is currently unprofitable.

Growing Profit Margin: 523489 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 523489 is unprofitable, and losses have increased over the past 5 years at a rate of 9.4% per year.

Accelerating Growth: Unable to compare 523489's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 523489 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (29.6%).


Return on Equity

High ROE: 523489's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies